← Leaderboards
Deborah Lynn French
Children'S Hosp Of Philadelphia
$725,460
Attributed
$2,176,381
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $692.4K · FY2015–18$1M$750K$500K$250K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$2,176,381 · 1
By mechanism
R01$2,176,381 · 1
Top collaborators
- Paul J Gadue5 shared
- Mortimer Poncz5 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Stella T Chou$21,048,327
- Paul J Gadue$9,372,986
- Seema Bhatnagar$10,006,203
- Akiva S Cohen$11,955,743
- Giovanni Ferrari$11,594,575
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroPlatelet TransfusionHematopoiesisInfusion ProceduresMegakaryocytesPlatelet Count MeasurementClinical ApplicationHalf-LifeHematopoietic Stem CellsInduced Pluripotent Stem CellBlood PlateletsIn VivoMethodologyNovel StrategiesCancer PatientAgonistGenerationsGrantAdultChemotherapyBloodHemorrhageCellsPloidies
Grant awards (5)
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2018 · HL
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2017 · HL
Optimization of Ex Vivo- and In Vivo- Generated Platelets$203,381
R01 · FY2017 · HL
Optimization of Ex Vivo- and In Vivo- Generated Platelets$489,000
R01 · FY2016 · HL
Optimization of Ex Vivo- and In Vivo- Generated Platelets$506,000
R01 · FY2015 · HL